FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Mifepristone Restrictions are Legal: Judge

A Washington federal judge says FDA acted lawfully in imposing restrictions on the availability of chemical abortion drugs mifepristone and misoprosto...

latest-news-card-1
Medical Devices

AirLife/Vyaire Recall Infant Heated Wire Circuits

AirLife and Vyaire recall certain infant heated wire circuits due to the risk that accessory adapters may unintentionally disconnect during setup or u...

latest-news-card-1
Human Drugs

Trethera Gets Fast Track for Prostate Cancer Drug

FDA grants Trethera a fast track designation for TRE-515 for treating prostate cancer.

latest-news-card-1
Human Drugs

Biotech Leaders Support Access to Mifepristone

A letter from dozens of biotechnology industry executives and investors urges FDA commissioner Marty Makary to reject efforts to restrict access to th...

latest-news-card-1
Human Drugs

FDA Drops REMS Need for ERA Meds

FDA drops REMS requirements covering embryofetal toxicity risk in endothelin receptor antagonists.

latest-news-card-1
Human Drugs

CGMP Violations at Exela Pharma Sciences

FDA warns Lenoir, NC-based Exela Pharma Sciences about CGMP violations in its work as a drug manufacturing outsourcing facility.

latest-news-card-1
Human Drugs

Support for Biosimilar Legislation

Forty health advocacy groups led by the Association for Accessible Medicines voice their support for legislation to eliminate the distinction between ...

latest-news-card-1
Human Drugs

FDA Prodded to Improve Surrogate Endpoint Transparency

A Federation of American Scientists online paper says FDA, other federal research agencies, and Congress should take steps to increase surrogate endpo...

latest-news-card-1
Human Drugs

Taiho Reports Unfavorable DMD Drug Data

Taiho Pharmaceutical reports disappointing data from its Phase 3 extension study of TAS-205 (pizuglanstat) in patients with Duchenne muscular dystroph...

latest-news-card-1
FDA General

FDA Urged to Expand Real-World Data Use

A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety and effectiveness of ...